Camsirubicin
MNPR-201-001
Phase 1 small_molecule terminated
Quick answer
Camsirubicin for Advanced Soft-tissue Sarcoma is a Phase 1 program (small_molecule) at Monopar Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Monopar Therapeutics
- Indication
- Advanced Soft-tissue Sarcoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated